Seroba Life Sciences Management Ltd 13D and 13G filings for Fusion Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-07-23 1:32 pm Purchase |
2020-06-30 | 13G | Fusion Pharmaceuticals Inc. FUSN |
Seroba Life Sciences Management Ltd | 2,021,646 4.850% |
2,021,646 (New Position) |
Filing |